Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2014
03/12/2014CN102657582B Application of toad peptide antibiotics in facial mask
03/12/2014CN102643377B Preparation method of homopolymerized N-vinyl butyl lactam iodine with 20% of effective iodine content
03/12/2014CN102631384B Application of pomegranate in preparing medicament for treating or preventing hepatitis B virus infection
03/12/2014CN102631356B Application of 4-dedimethyl tetracycline derivatives in aspect of resisting Helicobacter pylori
03/12/2014CN102600276B Traditional Chinese medicine compound capable of eliminating drug resistance of escherichia coli, as well as preparation method and application thereof
03/12/2014CN102585029B Preparation method and application of physiologically active notoginseng polysaccharide
03/12/2014CN102580118B Preparation method of shiga-like toxin Stx1B oral vaccine and product of shiga-like toxin Stx1B oral vaccine
03/12/2014CN102579927B Traditional Chinese medicine preparation for treating acquired immunodeficiency syndrome
03/12/2014CN102552901B Application of fullerene derivative to prepare gene transmission vector
03/12/2014CN102532312B Anti-Vibrio anguillarum yolk antibody, and preparation method, titer detection method and application thereof
03/12/2014CN102465137B Pichia pastoris for expressing rotavirus expression particles as well as preparation method and application of pichia pastoris
03/12/2014CN102451182B Preparation method of compound pseudoephedrine hydrochloride capsule
03/12/2014CN102417465B New tigecycline crystal form and preparation method thereof
03/12/2014CN102395579B Hepatitis c virus inhibitors
03/12/2014CN102395274B Anti-fungal formulation
03/12/2014CN102302456B Preparation method of tilmicosin phosphate microsphere specifically for use on animals
03/12/2014CN102266555B Method for preparing grass carp reovirus (GCRV) gene engineering vaccines
03/12/2014CN102229650B High purity lipopeptides, lipopeptide micelles and processes for preparing same
03/12/2014CN102210648B High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
03/12/2014CN102085377B Immunogenic composition and methods
03/12/2014CN102071219B Improved adenovirus vector and application thereof in medicine for preventing and treating AIDS (Acquired Immure Deficiency Syndrome)
03/12/2014CN101935303B Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/12/2014CN101925602B Crystalline form of abacavir that is essentially free of solvent
03/12/2014CN101921310B Dengue virus (DENV) specific HLA-A2 (Human Leukocyte Antigen-A2) restrictive epitope peptide and application thereof
03/12/2014CN101808627B Antiseptics
03/12/2014CN101784272B Antiviral composition comprising sulfated polysaccharide
03/12/2014CN101641114B Treatment of inflammation and/or endotoxic shock
03/12/2014CN101501063B Polymyxin derivatives and uses thereof
03/11/2014US8669237 Biodegradable immunomodulatory formulations and methods for use thereof
03/11/2014US8669234 Antiviral compounds
03/11/2014US8669226 Antimicrobial compositions and methods of use thereof
03/11/2014US8669081 Compositions useful as inhibitors of protein kinases
03/11/2014US8668934 Pharmaceutical formulation comprising a water-insoluble active agent
03/11/2014US8668912 Mycoplasma gallisepticum formulation
03/11/2014CA2618638C Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
03/11/2014CA2558829C Methods for treating viral infection using il-28 and il-29 cysteine mutants
03/11/2014CA2533358C Antibiotic product, use and formulation thereof
03/11/2014CA2533178C Antibiotic product, use and formulation thereof
03/11/2014CA2531684C Binding molecules against sars-coronavirus and uses thereof
03/11/2014CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
03/11/2014CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/10/2014CA2826708A1 Excipient system for topical delivery of pharmaceutical agents
03/06/2014WO2014036502A2 Tetracycline compounds
03/06/2014WO2014036244A1 Methods of administering a 5,5-fused heteroarylene hepatitis c virus inhibitor for treating of preventing hepatitis c virus infection
03/06/2014WO2014035961A1 Composition and use for increasing t cells
03/06/2014WO2014035345A1 Peptides and uses thereof
03/06/2014WO2014035297A1 Method and agent for the treatment and prophylaxis of diseases caused by (+)rna-containing viruses
03/06/2014WO2014035246A1 Antimicrobial composition
03/06/2014WO2014035064A1 The novel tenofovir disoproxil salt and the preparation method thereof
03/06/2014WO2014034842A1 Combination of sglt2 inhibitor and anti-hypertension drug
03/06/2014WO2014034719A1 Quinoline derivative having tlr inhibitory activity
03/06/2014WO2014034127A1 Binding/neutralizing human monoclonal antibodies against botulinum neurotoxin type b
03/06/2014WO2014033668A2 Combination of a macrocyclic protease inhibitor of hcv, a non-nucleoside hcv inhibitor and ritonavir
03/06/2014WO2014033617A1 2'-ethynyl nucleoside derivatives for treatment of viral infections
03/06/2014WO2014033597A1 5-azaindole compounds with anticancer and antiangiogenic activities
03/06/2014WO2014033561A1 Antibacterial compositions
03/06/2014WO2014033560A1 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
03/06/2014WO2014033497A1 5-azaindole compounds with anticancer and antiangiogenic activities
03/06/2014WO2014033490A1 Preventive products against pathogenic germs, and method for use thereof
03/06/2014WO2014033463A1 Prevention of the interaction between tenascin-c and mir-155 to treat sepsis
03/06/2014WO2014033366A1 Pharmaceutical compositions of anisomelic acid and the use thereof
03/06/2014WO2014033313A1 Protective anti-etec antibody
03/06/2014WO2014033266A1 Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection
03/06/2014WO2014033176A1 Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
03/06/2014WO2014033170A1 Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
03/06/2014WO2014033130A1 Cluster of differentiation 36 (cd36) as a therapeutic target for hiv infection
03/06/2014WO2014033077A1 Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at| least one of them is in the form of mini-tablets
03/06/2014WO2014032782A1 Jagaricin derivatives and their use as fungicide or antitumor agent
03/06/2014WO2014032541A1 Chinese medicinal preparation for treating aids and preparation method thereof
03/06/2014WO2014032481A1 Tenofovir prodrug and pharmaceutical uses thereof
03/06/2014WO2014032183A1 Dihydrochalcone derivatives and their use as antibiotic agents
03/06/2014WO2014032176A1 Methods for the treatment of hepatitis b and hepatitis d infections
03/06/2014WO2014012094A3 Tetracycline compounds for treating neurodegenerative disorders
03/06/2014WO2014011083A3 Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same
03/06/2014WO2014003850A3 Methods for treatment of ocular diseases
03/06/2014US20140065210 Protein stabilized probiotics and personal care products
03/06/2014US20140065189 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
03/06/2014US20140065188 Enterohemorrhagic Escherichia Coli Vaccine
03/06/2014DE112012001839T5 Caspofungin oder Salze davon mit hoher Reinheit sowie Herstellungsverfahren und Verwendung dafür Caspofungin or salts thereof having high purity and preparation method and use it
03/05/2014EP2703410A1 Jagaricin, derivatives, and uses thereof
03/05/2014EP2703409A1 Intermediate for synthesizing caspofungin and preparation method therefor
03/05/2014EP2703406A1 Novel cephem compound having catechol or pseudo-catechol structure
03/05/2014EP2703000A1 Application of dwarf lilyturf tuber polysaccharide extract in preparation of dietary supplement, health food or medicine with the function of weight loss
03/05/2014EP2702055A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
03/05/2014EP2701728A1 Formulation comprising crh and alpha - 2 - immunoglobulin
03/05/2014CN103620022A Method for amplifying nk cells
03/05/2014CN103619874A Soluble integrin [alpha]4 mutant
03/05/2014CN103619870A Epitope and its use of hepatitis b virus surface antigen
03/05/2014CN103619869A Macrocyclic compound and methods for its production
03/05/2014CN103619853A Cephem compound having pyridinium group
03/05/2014CN103619843A 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and use thereof in treating bacterial infections
03/05/2014CN103619836A Antimicrobial/adjuvant compounds and methods
03/05/2014CN103619356A Peptide oligonucleotide conjugates
03/05/2014CN103619344A A dietary supplement
03/05/2014CN103619341A Method of inhibiting harmful microorganisms and barrier-forming composition therefor
03/05/2014CN103619336A Sanglifehrin derivatives and methods for their production
03/05/2014CN103614399A Eriocheir sinensis lysozyme gene, encoding protein and application thereof
03/05/2014CN103614387A Optimized porcine circovirus type-2 Cap protein gene as well as recombinant plasmid application thereof
03/05/2014CN103614346A Method for harvesting viruses by utilization of harvest solution with high osmotic pressure
03/05/2014CN103614345A Influenza virus vaccine strain
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 1798